The clinical, histochemical, and molecular spectrum of PEO1 (Twinkle)-linked adPEO
| Autor: | Thomas Klopstock, Birgit Czermin, A Seller, Robert W. Taylor, Emma L. Blakely, Bryan Lecky, Grainne S. Gorman, Mark E Roberts, Benedikt Schoser, M Buddles, J Evans, S.E. Omer, Joanna Stewart, Douglass M. Turnbull, Cornelia Kornblum, Carl Fratter, Rita Horvath, Kate Craig, Joanna Poulton, Patrick F. Chinnery, S Rahman, Michael G. Hanna, C Smith |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2010 |
| Předmět: |
Adult
Male Mitochondrial DNA medicine.medical_specialty Pathology Ophthalmoplegia Chronic Progressive External Adolescent Biology medicine.disease_cause DNA Mitochondrial Ophthalmoparesis Mitochondrial Proteins Ptosis Molecular genetics medicine Humans Age of Onset Child Muscle Skeletal Genetic Association Studies Aged Mutation Muscle biopsy medicine.diagnostic_test DNA Helicases Skeletal muscle Articles Middle Aged Phenotype Mitochondria Muscle medicine.anatomical_structure Oculomotor Muscles Female Neurology (clinical) medicine.symptom |
| Popis: | Background: Mutations in the Twinkle (PEO1) gene are a recognized cause of autosomal dominant progressive external ophthalmoplegia (adPEO), resulting in the accumulation of multiple mitochondrial DNA (mtDNA) deletions and cytochrome c oxidase (COX)-deficient fibers in skeletal muscle secondary to a disorder of mtDNA maintenance. Patients typically present with isolated extraocular muscle involvement, with little apparent evidence of the clinical heterogeneity documented in other mtDNA maintenance disorders, in particular POLG-related disease. Methods: We reviewed the clinical, histochemical, and molecular genetics analysis of 33 unreported patients from 26 families together with all previous cases described in the literature to define the clinical phenotype associated with PEO1 mutations. Results: Ptosis and ophthalmoparesis were almost universal clinical features among this cohort, with 52% (17/33) reporting fatigue and 33% (11/33) having mild proximal myopathy. Features consistent with CNS involvement were rarely described; however, in 24% (8/33) of the patients, cardiac abnormalities were reported. Mitochondrial histochemical changes observed in muscle showed remarkable variability, as did the secondary mtDNA deletions, which in some patients were only detected by PCR-based assays and not Southern blotting. Moreover, we report 7 novel PEO1 variants. Conclusions: Our data suggest a shared clinical phenotype with variable mild multiorgan involvement, and that the contribution of PEO1 mutations as a cause of adPEO may well be underestimated. Direct sequencing of the PEO1 gene should be considered in adPEO patients prior to muscle biopsy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|